Hepatocyte growth factor protects human endothelial cells against advanced glycation end products-induced apoposis
- 1 June 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 344 (2) , 658-666
- https://doi.org/10.1016/j.bbrc.2006.03.167
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hepatocyte Growth Factor Protects against Hypoxia/Reoxygenation-induced Apoptosis in Endothelial CellsJournal of Biological Chemistry, 2004
- NF-κB2/p100 induces Bcl-2 expressionLeukemia, 2003
- Isolation of Bcl-2 Binding Proteins That Exhibit Homology with BAG-1 and Suppressor of Death Domains ProteinBiochemical and Biophysical Research Communications, 2001
- Contribution of Bcl-2, but Not Bcl-xL and Bax, to Antiapoptotic Actions of Hepatocyte Growth Factor in Hypoxia-Conditioned Human Endothelial CellsHypertension, 2001
- Autocrine FGF-2 Is Responsible for the Cell Density–Dependent Susceptibility to Apoptosis of HUVECArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- The IGF axis and programmed cell deathImmunology & Cell Biology, 1999
- Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome cPublished by Elsevier ,1996
- A License to KillCell, 1996
- The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.The Journal of cell biology, 1993
- Culture of Human Endothelial Cells Derived from Umbilical Veins. IDENTIFICATION BY MORPHOLOGIC AND IMMUNOLOGIC CRITERIAJournal of Clinical Investigation, 1973